Poly(ADP-ribose) polymerase suppression protects rheumatoid synovial fibroblasts from Fas-induced apoptosis

Rheumatology

Volumn 48, Issue 5, 2009, Pages 483-489

  García, Samuel ^a   Mera, Antonio ^a   Gómez Reino, Juan J ^a,b   Conde, Carmen ^a  

^a University Hospital of Santiago de Compostela   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Apoptosis; Fas associated death domain like IL 1b converting enzyme inhibitory protein; Phosphoinositol 3 kinase protein kinase B; Poly(ADP ribose) polymerase1; Rheumatoid arthritis

Indexed keywords

CYCLOHEXIMIDE; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEIN; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FLICE INHIBITORY PROTEIN; HOE 33342; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROCASPASE 8; PROTEIN KINASE B; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; ENZYME REPRESSION; FIBROBLAST; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; UPREGULATION; WESTERN BLOTTING;

ANTIGENS, CD95; APOPTOSIS; ARTHRITIS, RHEUMATOID; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASE 8; CELLS, CULTURED; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; FIBROBLASTS; GLYCOGEN SYNTHASE KINASES; HUMANS; PHOSPHORYLATION; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-AKT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SYNOVIAL MEMBRANE; TRANSFECTION;

EID: 65249168939     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken502     Document Type: Article

References (50)

1. Baier A, Meineckel I, Gay S, Pap T. Apoptosis in rheumatoid arthritis. Curr Opin Pharmacol 2003;15:274-79.
2. Firestein GS. Evolving concepts in rheumatoid arthritis. Nature 2003;423:356-61.
3. Pope RM. Apoptosis as a therapeutic tool in rheumatoid arthritis. Nature Rev Immunol 2002;2:527-35.
4. Peng SL. Fas (CD-95)-related apoptosis and rheumatoid arthritis. Rheumatology 2006;45:26-30.
5. Huber LC, Distler O, Tarner I, Gay RE, Gay S, Pap T. Synovial fibroblasts: Key players in rheumatoid arthritis. Rheumatology 2006;45:669-75.
6. Zhang HG, Wang Y, Xie JF et al. Regulation of tumor necrosis factor alpha-mediated apoptosis of rheumatoid arthritis synovial fibroblasts by the protein kinase Akt. Arthritis Rheum 2001;44:1555-67.
7. Miyashita T, Kawakami A, Tamai M et al. Akt is an endogenous inhibitor toward tumor necrosis factor-related apoptosis inducing ligand-mediated apoptosis in rheumatoid synovial cells. Biochem Biophys Res Commun 2003;312:397-404.
8. Chen Q, Casali B, Pattacini L, Boiardi L, Salvarani C. Tumor necrosis factor-α protects synovial cells from nitric oxide induced apoptosis through phosphoinositide 3-kinase Akt signal transduction. J. Rheumatol 2006;33:061-8.
9. Perlman H, Pagliari LJ, Liu H, Koch AE, Haines GK, Pope RM. Rheumatoid arthritis synovial macrophages express the Fas-associated death domain-like interleukin-1beta-converting enzyme-inhibitory protein and are refractory to Fas-mediated apoptosis. Arthritis Rheum 2001;44:21-30.
10. Palao G, Santiago B, Galindo M, Pallá M, Ramírez JC, Pablos JL. Down-regulation of FLIP sensitizes rheumatoid synovial fibroblasts to Fas-mediated apoptosis. Arthritis Rheum 2004;50:2803-10.
11. Bai S, Liu H, Chen K et al. NFκB-regulated expression of cellular FLIP protects rheumatoid arthritis synovial fibroblast from tumor necrosis factor α-mediated apoptosis. Arthritis Rheum 2004;50:3844-55.
12. Palao G, Santiago B, Galindo M et al. Fas activation of a proinflammatory program in rheumatoid synoviocytes and its regulation by FLIP and caspase 8 signaling. Arthritis Rheum 2006;54:1473-781.
13. Ashkenazi A, Dixit VM. Death receptors: Signaling and modulation. Science 1998;281:1305-08.
14. Green DR, Kroemer G. The pathophysiology of mitochondrial cell death. Science 2004;305:626-9.
15. Wajant H. The Fas signaling pathway: More than a paradigm. Science 2002;296:1635-6.
16. Liu H, Pope RM. The role of apoptosis in rheumatoid arthritis. Curr Opin Pharmacol 2003;3:317-22.
17. de Murcia G, Menissier-de Murcia J. Poly(ADP-ribose) polymerase: A molecular nick-sensor. Trends Biochem Sci 1994;19:17-6.
18. Shall S, de Murcia G. Poly(ADP-ribose) polymerase-1: What have we learned from the deficient mouse model? Mutat Res 2000;460:1-15.
19. Hong SJ, Dawson TM, Dawson VL. Nuclear and mitochondrial conversations in cell death: PARP-1 and AIF signaling. Trends Pharmacol Sci 2004;25:259-64.
20. Jagtap P, Szabo C. Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat Rev 2005;4:421-40.
21. Schreiber V, Dantzer F, Amè JC, de Murcia G. Poly(ADP-ribose): Novel functions for an old molecule. Nat Rev 2006;4:517-28.
22. Wang ZQ, Stingl L, Morrison C et al. PARP is important for genomic stability but dispensable in apoptosis. Genes Dev 1997;11:2347-58.
23. Simbulan-Rosenthal CM, Rosenthal DS, Iyer S, Boulares H, Smulson ME. Transient poly(ADP-ribosyl)ation of nuclear proteins and role of poly(ADP-ribose)polymerase in the early stages of apoptosis. J Biol Chem 1998;273:13703-12.
24. Oliver FJ, de la Rubia G, Rolli V, Ruiz-Ruiz MC, de Murcia G, Ménissier-de Murcia J. Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. J Biol Chem 1998;273:33533-9.
25. Diaz-Hernandez JI, Moncada S, Bolaños JP, Almeida A. Poly(ADP-ribose) polymerase-1 protects neurons against apoptosis induced by oxidative stress. Cell Death Differ 2007;14:1211-21.
26. Cohausz O, Blenn C, Malanga M, Althaus FR. The roles of poly(ADP-ribose)-metabolizing enzymes in alkylation-induced cell death. Cell Mol Life Sci 2008;65: 644-55.
27. Koh DW, Lawler AM, Poitras MF et al. Failure to degrade poly(ADP-ribose) causes increased sensitivity to cytotoxicity and early embryonic lethality. Proc Natl Acad Sci USA 2004;101:17699-704.
28. Blenn C, Althaus FR, Malanga M. Poly(ADP-ribose) glycohydrolase silencing protects against H2O2-induced cell death. Biochem J 2006;396:419-29.
29. García S, Bodaño A, González A, Forteza J, Gomez-Reino JJ, Conde C. Partial protection against collagen antibody-induced arthritis in PARP-1 deficient mice. Arthritis Res Ther 2006;8:R14-22.
30. García S, Bodaño A, Pablos JL, Gomez-Reino JJ, Conde C. Poly(ADP-ribose) polymerase inhibition reduces tumor necrosis factor-induced inflammatory response in rheumatoid synovial fibroblasts. Ann Rheum Dis 2008;67:631-7.
31. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1987;31:315-24.
32. Suhara T, Mano T, Oliveira BE, Walsh K. Phosphatidylinositol 3-kinase/ Akt signaling controls cell sensitivity to Fas-mediated apoptosis via regulation of FLICE-inhibitory protein (FLIP). Circ Res 2001;89:13-9.
33. S and induces caspase-8-dependent cell death in Jurkat T lymphocytes. Cell Death Differ 2005;12:233-42.
34. Moumen A, Ieraci A, Patané S et al. Met signals hepatocyte survival by preventing Fas-triggered FLIP degradation in a PI3K-Akt-dependent manner. Hepatology 2007;45:1210-7.
35. Moriyama H, Yonehara S. Rapid up-regulation of c-FLIP expression by BCR signaling through the PI3K/Akt pathway inhibits simultaneously induced Fas-mediated apoptosis in murine B lymphocytes. Immunol Lett 2007;109:36-46.
36. Tapodi A, Debreceni B, Hanto K et al. Pivotal role of Akt activation in mitochondrial protection and cell survival by poly(ADP-ribose)polymerase-1 inhibition in oxidative stress. J Biol Chem 2005;280:35767-75.
37. Yu SW, Wang H, Poitras MF et al. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 2002;297:259-63.
38. Andrabi SA, Kim NS, Yu SW, Wang H, Koh DW, Sasaki M. Poly(ADP-ribose) (PAR) polymer is a death signal. Proc Natl Acad Sci USA 2006;103:18308-13.
39. Oliver FJ, Ménissier-de Murcia J, Nacci C et al. Resistance to endotoxic shock as a consequence of defective NF-κB activation in poly (ADP-ribose) polymerase-1 deficient mice. EMBO J 1999;18:4446-54.
40. Zingarelli B, Szabo C, Salzman AL. Blockade of poly(ADP-ribose) synthetase inhibits neutrophil recruitment, oxidant generation, and mucosal injury in murine colitis. Gastroenterology 1999;116:335-45.
41. Mabley JG, Jagtap P, Perretti M et al. Anti-inflammatory effects of a novel, potent inhibitor of poly(ADP-ribose) polymerase. Inflamm Res 2001;50:561-9.
42. Mustapha O, Datta R, Oumouna-Benachour K et al. Poly(ADP-ribose) polymerase-1 inhibition prevents eosinophil recruitment by modulating Th2 cytokines in a murine model of allergic airway inflammation: A potential specific effect on IL-5. J Immunol 2006;177:6489-96.
43. Szabo C, Virag L, Cuzzocrea S et al. Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly (ADP-ribose) synthase. Proc Natl Acad Sci USA 1998;95:3867-72.
44. Gonzalez-Rey E, Martínez-Romero R, O'Valle F et al. Therapeutic effect of a poly(ADP-ribose) polymerase-1 inhibitor on experimental arthritis by downregulating inflammation and Th1 response. PloS ONE 2007;2:e1071.
45. Müller-Ladner U, Kriegsmann J, Gay RE, Gay S. Oncogenes in rheumatoid arthritis. Rheum Dis Clin North Am 1995;21:675-90.
46. Yamanishi Y, Boyle DL, Rosengren S, Green DR, Zvaifler NJ, Firestein GS. Regional analysis of p53 mutations in rheumatoid arthritis synovium. Proc Natl Acad Sci USA 2002;99:10025-30.
47. Müller-Ladner U, Kriegsmann J, Franklin BN et al. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol 1996;149:1607-15.
48. Krueger A, Schmitz I, Baumann S, Krammer PH, Kirchhoff S. Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex. J Biol Chem 2001;276:20633-40.
49. Krueger A, Baumann S, Krammer PH, Kirchhoff S. FLICE-inhibitory proteins: Regulators of death receptor-mediated apoptosis. Mol Cell Biol 2001;21: 8247-54.
50. Nesterov A, Lu X, Johnson M, Miller GJ, Ivashchenko Y, Kraft AS. Elevated Akt activity protects the prostate cancer cell line LNCaP from TRAIL-induced apoptosis. J Biol Chem 2001;276:10767-74.